These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 8536760

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Aspects of Bcl-2 proto-oncogene expression in dysplastic and malignant lesions of the uterine cervix].
    Borţun F, Chiovschi S, Moldovan M.
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(4):821-6. PubMed ID: 16004225
    [Abstract] [Full Text] [Related]

  • 3. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
    Giarnieri E, Mancini R, Pisani T, Alderisio M, Vecchione A.
    Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
    [Abstract] [Full Text] [Related]

  • 4. [Expression of aquaporin-8 and bcl-2 protein in human cervical carcinoma and their correlations].
    Yao JF, Zhou CY, Wei LF, Wang SY, Shi YF.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):205-8. PubMed ID: 18788571
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of bcl-2, p53 and Ki-67 in invasive squamous carcinoma of the uterine cervix.
    Padovan P, Salmaso R, Marchetti M, Padovan R.
    Eur J Gynaecol Oncol; 2000 Mar; 21(3):267-72. PubMed ID: 10949392
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
    Ishikawa H, Sakurai H, Hasegawa M, Mitsuhashi N, Takahashi M, Masuda N, Nakajima M, Kitamoto Y, Saitoh J, Nakano T.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):513-21. PubMed ID: 15380586
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
    Grace VM, Shalini JV, lekha TT, Devaraj SN, Devaraj H.
    Gynecol Oncol; 2003 Oct 01; 91(1):51-8. PubMed ID: 14529662
    [Abstract] [Full Text] [Related]

  • 11. Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues.
    Mozzetti S, Ferrandina G, Marone M, D'Ingiullo F, Fruscella E, De Pasqua A, Mancuso S, Scambia G.
    Cancer Detect Prev; 2000 Oct 01; 24(6):536-41. PubMed ID: 11198267
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix.
    Chang JL, Tsao YP, Liu DW, Han CP, Lee WH, Chen SL.
    Gynecol Oncol; 1999 Apr 01; 73(1):62-71. PubMed ID: 10094882
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis Phenomena in Squamous Cell Carcinomas and Adenocarcinomas of the Uterine Cervix.
    Eduardo MG, Campaner AB, Silva MA.
    Pathol Oncol Res; 2015 Sep 01; 21(4):887-92. PubMed ID: 25682239
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kokawa K, Shikone T, Otani T, Nakano R.
    Cancer; 1999 Apr 15; 85(8):1799-809. PubMed ID: 10223575
    [Abstract] [Full Text] [Related]

  • 17. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
    Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A, Liu S, Lu H, Verma A.
    Am J Pathol; 2003 Jun 15; 162(6):1789-806. PubMed ID: 12759237
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy.
    Jain D, Srinivasan R, Patel FD, Kumari Gupta S.
    Gynecol Oncol; 2003 Jan 15; 88(1):22-8. PubMed ID: 12504622
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.